FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and ...
GOLDEN VALLEY, Minn.--(BUSINESS WIRE)--Preceptis Medical, Inc. announced today that the Centers for Medicare & Medicaid Services (CMS) has finalized the creation of a new add-on G code to identify and ...
FRAMINGHAM, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical ...
UroGen Pharma (URGN) announced that the Centers for Medicare and Medicaid Services, CMS, has assigned a permanent Healthcare Common Procedure Coding System, HCPCS, Level II J Code, J9282, for ZUSDURI ...
CMS has announced it will begin reimbursing for four new Q codes effective for claims with dates of service on or after July 1. The new codes have an MPFSDB status indicator of E. CMS also announced ...
SALT LAKE CITY , Sept. 13, 2024 /PRNewswire/ -- Matia Mobility (https://www.matiamobility.com), a leader in durable medical equipment, is proud to announce that the Centers for Medicare & Medicaid ...
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver ...
Nationally Established Q Code Will Further Support the Use of Biovance® 3L by Physicians to Treat Wound Care Patients in Office Settings FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- ...
FRAMINGHAM, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback